Related Experiment Video

Updated: Sep 30, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K

MicroRNA-3200-3p targeting CAMK2A modulates the proliferation and metastasis of glioma in vitro

Haibin Wang1, Zhaobin Zeng1, Renhui Yi1

  • 1Department of Neurosurgery, The First Affiliated Hospital of Gannan Medical College, Ganzhou, Jiangxi, China.

Bioengineered
|March 15, 2022
PubMed

Insights

MicroRNA-3200-3p is downregulated in glioma, inhibiting cancer cell proliferation and metastasis. It targets CAMK2A, suggesting its potential as a therapeutic biomarker for glioma treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) play a crucial role in glioma pathogenesis.
  • The specific role and mechanism of miR-3200-3p in human glioma are not well understood.

Purpose of the Study:

  • To investigate the biological functions and underlying mechanisms of miR-3200-3p in human glioma.
  • To determine if miR-3200-3p can serve as a potential biomarker for glioma therapy.

Main Methods:

  • Quantification of miR-3200-3p levels in glioma cells.
  • Functional assays using miR-3200-3p mimics and inhibitors to assess effects on proliferation and metastasis.
  • Identification of direct target genes of miR-3200-3p.
  • Analysis of the Ras/Raf/MEK/ERK signaling pathway.

Main Results:

  • miR-3200-3p was significantly downregulated in human glioma cells.
  • Reduced miR-3200-3p levels correlated with increased glioma cell proliferation, colony formation, and metastasis.
  • Ca2+/calmodulin dependent kinase 2a (CAMK2A) was identified as a direct target of miR-3200-3p.
  • Overexpression of CAMK2A counteracted the tumor-suppressive effects of miR-3200-3p.
  • miR-3200-3p suppressed glioma proliferation and metastasis by inhibiting CAMK2A expression and regulating the Ras/Raf/MEK/ERK pathway.

Conclusions:

  • miR-3200-3p acts as a tumor suppressor in human glioma.
  • The miR-3200-3p/CAMK2A axis is a key regulator of glioma cell function.
  • miR-3200-3p holds potential as a diagnostic and therapeutic biomarker for glioma.
Keywords:
CAMK2AGliomametastasismiR-3200-3pproliferation

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.8K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K